Showing results (21-30 of 79) with videos related to

Sort By:
Pageof 8
Molecular and Cellular Biology|July 25, 2007
Downregulation of Rap1GAP contributes to Ras transformationOxana M Tsygankova, Gregory V Prendergast, Kanchan Puttaswamy, et al.
European Thyroid Journal|December 14, 2023
Real-world practice patterns and outcomes for RAI-refractory differentiated thyroid cancerAndrew G Gianoukakis, Jennifer H Choe, Daniel W Bowles, et al.
Neuro-Oncology|February 17, 2010
Activating mutations in BRAF characterize a spectrum of pediatric low-grade gliomasMargaret J Dougherty, Mariarita Santi, Marcia S Brose, et al.
Thyroid : Official Journal of the American Thyroid Association|December 21, 2019
Body Composition in Patients with Radioactive Iodine-Refractory, Advanced Differentiated Thyroid Cancer Treated with Sorafenib or Placebo: A Retrospective Analysis of the Phase III DECISION TrialOlivier Huillard, Anne Jouinot, Camille Tlemsani, et al.
Expert Review of Anticancer Therapy|October 27, 2012
Regional approaches to the management of patients with advanced, radioactive iodine-refractory differentiated thyroid carcinomaMarcia S Brose, Johannes Smit, Jaume Capdevila, et al.
Cancer Research|February 20, 2003
Constitutive mitogen-activated protein kinase activation in melanoma is mediated by both BRAF mutations and autocrine growth factor stimulationKapaettu Satyamoorthy, Gang Li, Michelle R Gerrero, et al.
The Lancet. Oncology|July 28, 2016
Vemurafenib in patients with BRAF(V600E)-positive metastatic or unresectable papillary thyroid cancer refractory to radioactive iodine: a non-randomised, multicentre, open-label, phase 2 trialMarcia S Brose, Maria E Cabanillas, Ezra E W Cohen, et al.
Journal of Patient-Reported Outcomes|December 18, 2024
Assessing tolerability with the Functional Assessment of Cancer Therapy item GP5: psychometric evidence from LIBRETTO-531, a phase 3 trial of selpercatinib in medullary thyroid cancerAntoine Regnault, Laurine Bunod, Angely Loubert, et al.
The Laryngoscope|May 3, 2006
Genome-wide profiling of oral squamous cell carcinoma by array-based comparative genomic hybridizationAnthony Sparano, Kelly M Quesnelle, Madhu S Kumar, et al.
The Journal of Molecular Diagnostics : JMD|August 11, 2007
Application of a BRAF pyrosequencing assay for mutation detection and copy number analysis in malignant melanomaCynthia Spittle, M Renee Ward, Katherine L Nathanson, et al.
Pageof 8